QA: REVELATION BIOSCIENCES INC. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001810560_2022_REVELATION_BIOSCIENCES_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001810560')"}

Graph

Absolute values for 0001810560, REVELATION BIOSCIENCES INC.

  xvar xval
0 AssetsCurrent 83,366
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 48,302,521
4 LiabilitiesCurrent 5,486,117
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,911,260
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,088,248
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 957,623
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 48,385,887
1 Liabilities 8,397,377
2 Expenses 3,088,248
3 Revenues 0
4 StockholdersEquity 39,988,510
5 NetIncome -2,130,625
6 ComprehensiveNetIncome -2,130,625
7 BaseVar 30,414,568
8 EconomicCapitalRatio 2.35

Edgar->Model Mapping

Feature Distribution

Change over Time